BI
IRMD icon

Binnacle Investments’s iRadimed IRMD Stock Holding History

Binnacle Investments’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$18.9K Buy
266
+57
+27% +$3.8K 0.01% 288
2025
Q2 		$12.5K Buy
209
+75
+56% +$4.11K 0.01% 325
2025
Q1 		$7.03K Buy
+134
New +$7.53K 0.01% 387

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Binnacle Investments's IRMD Position: Q3 2025 in Review

Binnacle Investments increased its iRadimed (IRMD) stake by 27% in Q3 2025, buying an estimated $3.8K and bringing the position to 266 shares worth $18.9K. The position accounts for 0.01% of the portfolio, ranked #288.

Binnacle Investments first reported a position in IRMD in Q1 2025 and has held it in 3 quarters since. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.

  • Binnacle Investments held 266 shares of iRadimed worth $18.9K as of Q3 2025.
  • Binnacle Investments bought 57 iRadimed shares in Q3 2025, an estimated $3.8K.
  • iRadimed made up 0.01% of Binnacle Investments's portfolio in Q3 2025, its #288 holding.
  • Binnacle Investments first reported a position in iRadimed in Q1 2025 and has held it in 3 quarters since.
  • 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.